Found 26 matching trials
Efficacy of MIrikizumab to Achieve Transmural Healing in patiENTs With Crohn's Disease PHASE4 Efficacy of Mirikizumab to achieve transmural healing in patients with Croh...
Show More Location
CHU de Brest - Hôpital de la Cavale Blanche
Learn More & Join Trial
A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease PHASE2 The purpose of this study is to evaluate the safety and effectiveness of th...
Show More Location
Longwood Research
Learn More & Join Trial
A Safety Study of Mirikizumab (LY3074828) PHASE1 The main purpose of this study is to evaluate the safety of the study drug ...
Show More Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Learn More & Join Trial
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease PHASE2 The main purpose of this study is to see how the safety and efficacy of a f...
Show More Location
Mayo Clinic in Arizona - Scottsdale
Learn More & Join Trial
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Colitis PHASE3 The main purpose of this study is to investigate efficacy, pharmacokinetics...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD PHASE4 This is an open-label, single-arm, phase 4 study to assess the safety and e...
Show More Location
Digestive & Liver Center of Florida
Learn More & Join Trial
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis: PHASE2 The main purpose of the study is to evaluate the effectiveness and safety o...
Show More Location
Mayo Clinic in Arizona - Scottsdale
Learn More & Join Trial
A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease PHASE3 The reason for this study is to see if the study drug mirikizumab is safe a...
Show More Location
University of Alabama-The Kirklin Clinic
Learn More & Join Trial
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON) PHASE3 The main purpose of this study is to evaluate the long-term efficacy of mir...
Show More Location
UCSF Medical Center at Mission Bay
Learn More & Join Trial
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease PHASE3 Study participants will be screened during the platform study and randomly ...
Show More Location
Cedars Sinai Medical Center
Learn More & Join Trial